2012 CSHL Retroviruses Conference

描述(由申请人提供)：本提案寻求支持将在冷泉港实验室举行的关于“逆转录病毒”的年度系列会议中的第三十七次，该会议已成为该领域的首要会议。拟议中的会议将召集该领域的领导人、初级教师、博士后研究员和研究生，讨论逆转录病毒生物学领域的新的前沿发展。这一系列会议的重点是病毒及其与宿主细胞的相互作用，而不是它们引起的特定疾病。将展示的大部分作品将是未出版的，并受到观众的即时评论和讨论。2012年的会议将以与病毒生物学平行的方式组织；从复制周期的进入阶段开始，从进入后事件开始，包括反转录和整合、与RNA相关的事件(转录、加工、输出和包装)、颗粒组装和释放、致病/宿主因素，最后是抗病毒药物和进化。选定的演讲者将包括研究生、博士后研究员和初级教员。每期会议将由组织者从报名人员中挑选的两名该领域的领先科学家担任主席。两位著名的受邀演讲者将进行特别演讲，以激励和告知年轻科学家，并鼓励从事相关但不同领域的科学家之间的讨论。还将有三个海报会议，大多数参与者可以展示他们的作品。这次会议将是中等规模的，我们预计将有大约450名逆转录病毒学家出席。

DESCRIPTION (provided by applicant): This proposal seeks support for the thirty-seventh in an annual series of meetings on "Retroviruses" to be held at Cold Spring Harbor Laboratory that has emerged as the premiere conference for this field. The proposed meeting will assemble leaders in the field, junior faculty, postdoctoral fellows and graduate students to discuss new, cutting-edge developments in the field of retrovirus biology. The meeting series is focused on the viruses and their interactions with host cells rather than the particular diseases they cause. The large majority of the work to be presented will be unpublished and subject to immediate comment and discussion by the audience. The 2012 meeting will be structured in a manner that parallels the biology of the viruses; beginning with the entry phase of the replication cycle, proceeding with post-entry events, including reverse transcription and integration, RNA-related events (transcription, processing, export, and packaging), particle assembly and release, pathogenesis/host factors, and concluding with antivirals and evolution. Selected speakers will include graduate students, postdoctoral fellows and junior faculty. Each session will be chaired by two leading scientists in the field selected by the organizers from among the registrants. Two eminent invited speakers will give special lectures to inspire and inform young scientists and to stimulate discussion between scientists working on related but distinct areas. There will also be three poster sessions where a majority of participants can present their work. The meeting will be of moderate size, and we expect ~450 retrovirologists in attendance.